MHRA device registration: DORS, fees and Northern Ireland
MHRA device registration for Great Britain runs through DORS. See who registers, what to prepare, the £300 category fee, PARD and the NI route.
MHRA device registration: who registers, DORS, fees and NI
MHRA device registration for Great Britain is done in the Device Online Registration System (DORS), by the manufacturer or, for a manufacturer outside the UK, its UK Responsible Person. The device must be confirmed as registered before it is placed on the GB market. From 1 April 2026 the fee is £300 a year per GMDN Level 2 category, or per Level 1 category where no Level 2 exists (MHRA registration guidance).
Registration is not MHRA approval or a substitute for conformity assessment. MHRA prohibits claims or logo use suggesting accreditation, certification or endorsement (MHRA).
Who must register with the MHRA
Great Britain means England, Scotland and Wales. MHRA says all medical devices must be registered before they are placed on the GB market. That includes IVDs, custom-made devices and systems or procedure packs. The guidance covers selling, leasing, lending and gifting, so supplying a device free of charge is not a general exemption. It also covers devices that a supplier manufactures, refurbishes or relabels under its own name (MHRA).
For devices only put into service, MHRA encourages registration but does not require it. This includes devices made and used on site without marketing or distribution (MHRA).
The roles split like this:
| Role | Duty for GB supply |
|---|---|
| UK-based manufacturer | Registers its own devices in DORS |
| Manufacturer outside the UK | Appoints a single UK Responsible Person (UKRP), which takes on the registration duty |
| GB importer | Notifies the manufacturer or UKRP, which supplies the importer details to MHRA |
| Distributor that does not import | Does not register just for distributing |
The test for needing a UKRP is a manufacturer outside the UK, not just outside GB. The UKRP designation letter is a legal contract that confirms exclusivity and the mandatory tasks. One organisation can act as both importer and UKRP, but the roles stay distinct (MHRA, MHRA UK overview).
How to register in DORS
MHRA's guidance supports this sequence (MHRA):
- Confirm the product is a medical device or IVD, and establish its class, the legislation that applies and the intended market.
- Request a DORS account. MHRA emails you to accept or reject it.
- Add the manufacturer or representative details, the device data and the relevant conformity documents.
- Pay through DORS. For BACS or CHAPS, use the unique DORS payment reference.
- Wait for confirmation that the device is registered before you place it on the GB market. MHRA may ask for more technical documentation. Account acceptance, submission and payment alone do not confirm device registration.
Prepare this non-exhaustive checklist from MHRA's guidance:
- the manufacturer's legal name and address, matching the label and packaging, plus company type and an administrative contact
- the UKRP designation letter, where relevant
- device class, applicable legislation, and the GMDN code and term
- trade name, model or version, and catalogue or reference number
- Basic UDI-DI and UDI-DI, where applicable
- the approved or notified body where applicable, relevant device characteristics, and applicable conformity certificates or self-certification declarations
You don't need to be a member of the GMDN Agency to select terms in DORS. Not every GMDN code or term is treated as a medical device in the UK (MHRA).
MHRA fees for device registration
The old one-off fee ended on 1 April 2026. For 1 April 2026 to 31 March 2027 the charge is £300 a year per GMDN Level 2 category, or per Level 1 category where no Level 2 exists (MHRA registration guidance, MHRA current fees, section 7d, SI 2026/197).
The charge follows the GMDN category, not each SKU, model or GMDN term. Several products in the same category do not each add a category charge. A product that falls under more than one of those categories is charged once a year. Use the amount DORS assesses for your account (MHRA).
A registration made during the 1 April to 31 March charging period is charged pro rata. MHRA calculates the annual fee from the Level 2 GMDN categories that the registrations fall under on 31 March (MHRA). The annual maintenance fee starts in the fee period after the one in which you paid the registration fee (regulation 53).
MHRA's November 2026 update says the 2026/27 recalculation is complete, with put-into-service-only registrations excluded and revised amounts shown in DORS. Outstanding annual fees were due on 6 November 2026, and accounts still unpaid after that date have been suspended. MHRA says this fee will change annually (MHRA). If your account shows a suspension, check its fee status in DORS.
Keeping a registration up to date
MHRA removed the old "Renew registration" function on 1 April 2026. You still need to review the registration frequently and notify changes. Address and contact changes are free, and so is adding products to existing registered devices. A new chargeable category, and some other changes, can attract a fee (MHRA).
What the PARD database shows
The Public Access Registration Database (PARD) is the public MHRA medical device registration database. For each registration it shows the manufacturer's name and address, the MHRA reference or account number, the registered GMDN device types with their five-digit GMDN codes, and brand or trade names (MHRA).
UK Responsible Person or Northern Ireland authorised representative details appear inside the manufacturer's record where they apply. MHRA says PARD can't currently be searched by representative. IVDs under performance evaluation are not published (MHRA).
Northern Ireland follows EU rules
Northern Ireland applies the EU MDR and IVDR. Since 28 May 2026, non-custom-made devices must be registered on EUDAMED before placement on the NI market, and MHRA registration has not been required from that date. A GB manufacturer placing a device on the NI market must appoint an authorised representative based in the EU or Northern Ireland (MHRA, MHRA NI guidance).
Custom-made devices are the exception. They stay with MHRA and must be registered within 28 days of being made available on the NI market, wherever the manufacturer is based. An NI authorised representative may register on the manufacturer's behalf. If the representative is in the EU, the manufacturer registers. One DORS account can hold both GB and NI records (MHRA).
On the EU side, the first four EUDAMED modules became mandatory on 28 May 2026, not all six (European Commission). Devices already on the market, including legacy devices, have their own transitional data-entry rules under Regulation (EU) 2024/1860. Check which transition applies to each device. If NI goods also go into GB, check MHRA's guidance for that specific case before you assume either registration covers both.
RegAffairs AI has a cited answer on registering a device with the MHRA.